NYC Health News

"> ">

NYC Expands SNAP Health Bucks Benefits by 40%

New York City residents receiving SNAP benefits will have additional purchasing power at participating farmers markets beginning January 2027. Mayor Zohran Mamdani announced that the Health Bucks program will raise its daily incentive limit from $10 to $14, allowing eligible shoppers to receive more assistance when buying fresh fruits and vegetables. The city projects distributing approximately $2.3 million in incentives during 2027, benefiting households and local produce vendors. Available at more than 100 participating locations, the expanded program aims to address rising grocery costs and food insecurity while encouraging healthier eating habits across New York City's five boroughs.

"> ">

Mount Sinai Ranks No. 3 Among World's Smart Hospitals

Mount Sinai Hospital has secured the third spot globally in Newsweek's latest smart hospital rankings, advancing two positions while remaining New York State's highest-ranked institution. The recognition comes as the NYC health system expands artificial intelligence applications designed to improve medical decisions and patient experiences. One initiative uses AI to identify older hospitalized patients at increased risk of delirium, helping medical teams intervene earlier. Mount Sinai has also introduced digital tools that guide patients toward appropriate care. Additional recognition from CHIME highlights the hospital system's investments in digital infrastructure, cybersecurity, clinical technology, and more accessible health care services.

"> ">

NY Health Insurance Open Enrollment Starts Nov. 1

The New York State Department of Health has announced that open enrollment for 2027 Qualified Health Plans begins November 1, 2026, and continues through January 31, 2027. Residents seeking coverage beginning January 1 are encouraged to enroll by December 15. More than 800,000 New Yorkers are up for renewal statewide across NY State of Health programs. The Marketplace offers Qualified Health Plans, Medicaid, Child Health Plus and the Essential Plan, with free assistance available through more than 9,000 enrollment assistors. Officials are also encouraging residents affected by federal eligibility changes to review their coverage options. Oscar Health will no longer participate in the Marketplace for 2027, requiring approximately 4,800 affected consumers to select another plan.

"> ">

NYU Study Finds New Drug Reduces Cancer Death Risk

An international phase 3 clinical trial led by researchers at NYU Langone Health's Perlmutter Cancer Center found that sacituzumab tirumotecan, a targeted cancer drug, improved outcomes for patients with previously treated advanced or recurrent endometrial cancer. Among 776 women, those assigned to the drug had a 41% lower relative risk of disease progression and a 32% lower relative risk of death compared with patients receiving standard chemotherapy. Tumor responses occurred in 35.1% of patients receiving sacituzumab tirumotecan, compared with 17.3% in the chemotherapy group. The findings, scheduled for presentation October 26 and publication in The Lancet, could inform future treatment guidelines, although regulatory status and longer-term outcomes require clarification.

"> ">

NYC Launches SNAP and Medicaid Work Rules Website

New York City has launched an online resource to help residents understand federal SNAP and Medicaid work requirements, identify potential exemptions and maintain access to food and healthcare assistance. Available at NYC.gov/workrules, the webpage guides users through questions about age, employment, education and other circumstances to explain which requirements may apply. It also connects residents with benefits hotlines, food assistance, job opportunities, approved volunteer activities and NYC Care. Expanded SNAP work requirements took effect March 1, 2026, while additional Medicaid requirements are scheduled to begin January 1, 2027. City officials say their outreach efforts have helped more than 220,000 New Yorkers at risk of losing SNAP benefits.

"> ">

NYU Langone Names Ishwaria Subbiah to Cancer Role

NYU Langone Health has appointed Dr. Ishwaria Subbiah as director of the Symptom Management Program for hematology and medical oncology at Perlmutter Cancer Center, effective November 1, 2026. She will also serve as an associate professor of medicine at NYU Grossman School of Medicine. A specialist in supportive and palliative care and integrative oncology, Dr. Subbiah will lead efforts to improve management of cancer treatment side effects, including pain, fatigue, nausea and neuropathy. She brings more than 16 years of patient care experience and previously held a faculty position at MD Anderson Cancer Center. Her work includes clinical trials, technology-enabled symptom monitoring and programs designed to improve patients' quality of life during treatment.

"> ">

Gotham Health Expands Child Development Care in Bronx

NYC Health + Hospitals/Gotham Health is expanding developmental-behavioral pediatric care at its Morrisania location in the Bronx, building on services at St. Nicholas in Harlem. The multidisciplinary program brings together pediatric specialists, speech and occupational therapists, psychologists, physiatrists and social workers to support children with autism, developmental delays, learning difficulties and behavioral challenges. Between April and October 2026, the two locations recorded 5,151 developmental pediatrics encounters, including 4,441 at Morrisania and 710 at St. Nicholas. Dr. John Gaipa provides specialized developmental care at Morrisania, while Dr. Tyrone Bentley leads developmental evaluation services at St. Nicholas. Families can learn more or request appointments through Gotham Health's central scheduling line.

"> ">

Weill Cornell Gets $8.2M for Male Birth Control Pill

Weill Cornell Medicine has received an $8.2 million federal grant to advance an experimental male birth control pill designed to temporarily stop sperm from swimming. Led by pharmacology professors Dr. Jochen Buck and Dr. Lonny Levin, the four-year research project aims to develop an on-demand contraceptive that men could take approximately 30 minutes before sex, with effects lasting six to eight hours. Earlier preclinical research found that blocking an enzyme involved in sperm movement could prevent pregnancy in experimental models. The new funding will support drug formulation, manufacturing, safety studies and preparations for an initial human clinical trial. The pill is not approved for human use, and researchers must establish its safety and effectiveness before it could become a contraceptive option.

"> ">

NYC Opens $200K LGBTQIA+ Community Grant Program

New York City is accepting applications for $200,000 in grants to support nonprofit and community-based organizations serving LGBTQIA+ residents across the five boroughs. The 2026–2027 NYC Unity Grant Program will award ten organizations $20,000 each for projects addressing education and employment, housing and economic stability, or health and well-being. Priority will be given to initiatives supporting transgender, gender nonconforming, nonbinary and intersex New Yorkers, LGBTQIA+ people of color, and other underserved communities. Eligible organizations must be NYC-based nonprofits or have fiscal sponsors and primarily serve LGBTQIA+ city residents. Applications are due November 16, 2026, with a virtual information session scheduled for November 2. Selected organizations are expected to be notified by December 11.